twenty-nine patients with non-small cell lung cancer refractory to prior therapy were treated with either vindesine ( vds ) alone ( 3 mg/m2 every week ) or the combination of vds plus cisplatin ( ddp ) ( 100 mg/m2 every 28 days ) .
C0042682
vindesine
C0280545
vds